Rossari Biotech Ltd
Chemicals & Petrochemicals | Small Cap
Health Score : 8.34Rossari Biotech demonstrates a mixed financial performance. The company shows strong solvency and growth, indicating a solid foundation and expansion capabilities. Profitability is also a notable strength. However, efficiency and liquidity present challenges. While solvency and growth are robust, the company needs to address its efficiency in asset utilization and ensure sufficient short-term liquidity to meet its immediate obligations. Overall, Rossari Biotech exhibits promising growth and profitability, but improvements in operational efficiency and liquidity management are essential for sustained success.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio5.60
- Profitability Ratio10.00
- Efficiency Ratio4.00
- Coverage Ratio10.00
- Solvency Ratio10.00
- Liquidity Ratio5.86
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekNeutral
- 1 MonthNeutral
Health Score : 8.34Rossari Biotech demonstrates a mixed financial performance. The company shows strong solvency and growth, indicating a solid foundation and expansion capabilities. Profitability is also a notable strength. However, efficiency and liquidity present challenges. While solvency and growth are robust, the company needs to address its efficiency in asset utilization and ensure sufficient short-term liquidity to meet its immediate obligations. Overall, Rossari Biotech exhibits promising growth and profitability, but improvements in operational efficiency and liquidity management are essential for sustained success.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
21.75
Industry Median
29.91
Small Cap Median
28.59
P/E RATIO
20.82
P/B RATIO
2.33
Industry Median
2.51
Small Cap Median
2.38
P/S RATIO
1.37
Industry Median
2.22
Small Cap Median
1.92
Others
PEG RATIO
0.00
EV/EBITDA RATIO
10.67
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹560.9 as on Jun 21, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤27th Apr 26
Consolidated Financial Results for Q4 and Year Ended March 31, 2026
UNDEFINED SENTIMENT
Concall Report⬤23rd Jan 26
Q3 FY26 Earnings Conference Call
NEUTRAL SENTIMENT
Growth Score : 10.00The company demonstrates excellent growth across all metrics, including revenue, operating profit, EPS, assets, and net income. This indicates strong expansion and increasing profitability. The company is growing very fast.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 109.17 | 11.67 | 10.57 | 13.6 | 15.19 |
| Operating Profit Growth Rate | 48.39 | 21.2 | 12.11 | 6 | 7.92 |
| Earnings Per Share (EPS) Growth | 14.82 | 9.64 | 21.65 | 4.1 | 9.38 |
| Asset Growth Rate | 123.71 | 8.69 | 14.88 | 20.36 | 21.37 |
| Net Income Growth Rate | 22.5 | 9.18 | 22.43 | 3.82 | 9.56 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Financial Score : 5.60The company's financial ratios present a mixed picture. While adjusted EPS, cash EPS, and book value per share are performing well, the dividend per share and capital expenditures scores are low. This suggests strong earnings and asset value but less attractive dividend payouts and higher investments in capital assets. The company needs to improve on its capital expenditure.
Adjusted Earnings Per Share (Adjusted EPS)GoodCash Earnings Per Share (Cash EPS)GoodBook Value Per ShareGood
Dividend Per Share (DPS)PoorCapital Expenditures (CapEx)Poor| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 17.82 | 19.45 | 23.64 | 24.73 | 27.09 |
| Cash Earnings Per Share (Cash EPS) | 26.55 | 30.91 | 34.73 | 36.91 | 41.45 |
| Book Value Per Share | 146.36 | 166.36 | 190.55 | 215.45 | 242.36 |
| Dividend Per Share (DPS) | 0.53 | 0.58 | 0.47 | 0.49 | 0.54 |
| Capital Expenditures (CapEx) | 36 | 31 | 126 | 159 | 241 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
Profitability Score : 10.00The company exhibits excellent profitability, demonstrating high gross profit margin, ROCE, ROE, ROA, operating margin, and net margin. This indicates efficient operations and strong financial performance. The company is very good in terms of profitability.
Gross Profit MarginExcellentReturn on Capital Employed (ROCE)ExcellentReturn on Equity (ROE)ExcellentReturn on Assets (ROA)ExcellentOperating MarginExcellentNet MarginExcellent| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 9.17 | 9.66 | 10.38 | 9.52 | 8.64 |
| Return on Capital Employed (ROCE) | 24 | 18 | 18 | 16 | 15 |
| Return on Equity (ROE) | 12.17 | 11.69 | 12.5 | 11.48 | 11.18 |
| Return on Assets (ROA) | 14.66 | 16.35 | 15.95 | 14.05 | 12.49 |
| Operating Margin | 12.41 | 13.47 | 13.65 | 12.74 | 11.94 |
| Net Margin | 6.61 | 6.46 | 7.15 | 6.54 | 6.22 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
Efficiency Score : 4.00The company's efficiency in utilizing its assets is not good. While inventory management is average, fixed asset turnover, receivables turnover, and capital turnover are low. The receivable days is high. This indicates potential inefficiencies in generating revenue from assets and managing working capital, which could impact overall profitability and cash flow.
Fixed Asset Turnover RatioWeakInventory Turnover RatioAverageReceivables Turnover RatioWeakDays Sales in Inventory RatioAverageReceivable DaysPoorCapital Turnover RatioPoor| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.44 | 2.83 | 3.17 | 3.48 | 2.95 |
| Inventory Turnover Ratio | 9.45 | 7.92 | 6.98 | 5.91 | 5.76 |
| Receivables Turnover Ratio | 6.61 | 5.03 | 4.7 | 4.63 | 4.65 |
| Days Sales in Inventory Ratio | 38.62 | 46.09 | 52.29 | 61.76 | 63.37 |
| Receivable Days | 55.22 | 72.56 | 77.66 | 78.83 | 78.49 |
| Capital Turnover Ratio | 1.84 | 1.74 | 1.67 | 1.58 | 1.65 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
Coverage Score : 10.00The company exhibits excellent coverage ratios, indicating a strong ability to meet its interest and dividend obligations. This reflects financial stability and security for investors. The company is very well positioned to meet its interest and dividend obligations.
Interest Coverage RatioExcellentEquity Dividend Coverage RatioExcellent| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 11.46 | 7.55 | 10.37 | 11.28 | 8 |
| Equity Dividend Coverage Ratio | 33.33 | 33.33 | 50 | 50 | 50 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
Solvency Score : 10.00The company's solvency position is very strong, as indicated by the excellent scores across all metrics. This suggests a very low risk of financial distress and a strong ability to meet long-term obligations. The company has a very strong financial foundation.
Debt RatioExcellentDebt to Equity RatioExcellentEquity RatioExcellentDebt To Asset RatioExcellent| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0 | 0.04 | 0.04 | 0.1 | 0.08 |
| Debt to Equity Ratio | 0 | 0.04 | 0.04 | 0.11 | 0.09 |
| Equity Ratio | 1 | 0.96 | 0.96 | 0.9 | 0.92 |
| Debt To Asset Ratio | 0 | 0.03 | 0.03 | 0.07 | 0.05 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
Liquidity Score : 5.86The company's liquidity position shows a mixed performance. While the quick ratio suggests an ability to meet short-term obligations, the cash and operating cash flow ratios indicate potential difficulties in covering immediate liabilities with cash and operational cash. This might affect its ability to handle unforeseen expenses or invest in growth opportunities. The current ratio is at par. Having a good quick ratio is a positive aspect for the company.
Current RatioAverageQuick RatioGoodCash RatioWeakOperating Cash Flow RatioWeak| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.36 | 1.72 | 1.86 | 1.86 | 1.52 |
| Quick Ratio | 0.94 | 1.27 | 1.26 | 1.24 | 1.04 |
| Cash Ratio | 0.12 | 0.3 | 0.06 | 0.1 | 0.11 |
| Operating Cash Flow Ratio | 0.06 | 0.37 | 0.09 | 0.24 | 0.08 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | J.G.Chemicals Ltd | 9.23 | 26.03 | Neutral | 82.00 | 5.47 | 69.00 |
| 2 | Platinum Industries Ltd | 8.59 | 24.13 | Neutral | 60.00 | 9.75 | 51.00 |
| 3 | Fineotex Chemical Ltd | 8.39 | 46.80 | Neutral | 135.00 | 0.79 | 125.00 |
| 4 | Rossari Biotech Ltd | 8.34 | 20.82 | Neutral | 286.00 | 25.79 | 149.00 |
| 5 | Vidhi Specialty Food Ingredients Ltd | 8.25 | 29.02 | Neutral | 78.00 | 9.84 | 49.00 |
| 6 | Bhansali Engineering Polymers Ltd | 8.25 | 14.62 | Undervalued | 216.00 | 7.25 | 180.00 |
| 7 | Styrenix Performance Materials Ltd | 8.12 | 22.24 | Undervalued | 343.00 | 133.22 | 183.00 |
| 8 | Balaji Amines Ltd | 7.79 | 41.44 | Overvalued | 265.00 | 51.09 | 169.00 |
| 9 | Tatva Chintan Pharma Chem Ltd | 7.13 | 66.41 | Overvalued | 93.00 | 16.71 | 42.00 |
| 10 | Laxmi Organic Industries Ltd | 6.17 | 53.28 | Neutral | 171.00 | 2.86 | 79.00 |
| 11 | Yasho Industries Ltd | 6.09 | 137.40 | Neutral | 143.00 | 17.81 | 25.00 |
| 12 | Neogen Chemicals Ltd | 5.97 | 177.25 | Highly Overvalued | 137.00 | 17.15 | 29.00 |
| 13 | Camlin Fine Sciences Ltd | 5.80 | 97.42 | Neutral | 107.00 | -1.72 | 24.00 |
| 14 | NOCIL Ltd | 5.27 | 47.75 | Neutral | 101.00 | 3.84 | 56.00 |
| 15 | Chemplast Sanmar Ltd | 4.81 | -12.12 | Neutral | 198.00 | -63.46 | -280.00 |
Balanced ManagementRossari Biotech's management effectiveness reveals a mixed performance. While the company has achieved substantial sales growth over the past five years, there are concerns regarding declining ROCE and an extended cash conversion cycle, suggesting potential challenges in effectively managing capital and working capital. Although sales growth persists, the deceleration in compounded profit growth implies that profitability isn't keeping pace with revenue expansion. These factors indicate that management should prioritize enhancing operational efficiencies and profitability to ensure sustainable long-term growth.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Compounded Sales Growth (5 Years) | 28% | Strong revenue expansion |
| CONS | Return on Capital Employed (Latest Year) | 16% | Declining capital efficiency |
| Cash Conversion Cycle (Latest Year) | 101 Days | Increasing working capital needs | |
| Compounded Profit Growth (TTM) | 5% | Profitability growth slowing |
Financial Performance & GrowthAverageCapital Efficiency & ReturnsWeakFinancial Health & PrudenceAverageShareholding & Ownership StructureGoodFinancial Performance & Growth
Rossari Biotech showcases strong sales growth, but profit growth has not kept pace. The compounded sales growth over the past 5 years is 28%, indicating robust revenue expansion. However, the compounded profit growth has slowed to 5% TTM. Quarterly sales show consistent growth, but YOY profit growth has been volatile, ranging from -8% to 38%. The OPM has remained relatively stable. This mixed performance suggests that while the company is growing its sales effectively, it faces challenges in maintaining profitability.
| Metric | 2021-2023 | 2024 | 2025 |
|---|---|---|---|
| Sales Growth (%) | 43.3% | 10.6% | 13.6% |
| OPM (%) | ~13% | 14% | 13% |
Capital Efficiency & Returns
The capital efficiency of Rossari Biotech shows a concerning trend. ROCE has declined from 38% in March 2020 to 16% in March 2025, indicating a decrease in the effectiveness of capital utilization. ROE has also decreased from 14% (5 year average) to 12% in the last year. The cash conversion cycle has increased from 6 days in March 2019 to 101 days in March 2025, suggesting less efficient working capital management.
| Metric | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROCE (%) | 38% | 24% | 18% | 18% | 16% |
| Cash Conv. Cycle (Days) | 19 | 76 | 80 | 103 | 101 |
Financial Health & Prudence
Rossari Biotech's debt management shows an increasing reliance on borrowings. The Debt/Equity ratio has increased from 0.07 in March 2019 to 0.19 in March 2025, indicating higher financial leverage. Interest coverage can be derived from Operating Profit and Interest paid. The interest coverage ratio has decreased from 26 in 2019 to 14.72 in 2025. Dividend payout has remained consistently low, around 2-4%.
| Metric | 2019 | 2021 | 2023 | 2025 |
|---|---|---|---|---|
| Debt/Equity Ratio | 0.07 | 0.00 | 0.08 | 0.19 |
Shareholding & Ownership Structure
The promoter holding in Rossari Biotech is strong. Promoter holding has slightly decreased from 72.69% in March 2021 to 68.18% in March 2025. Institutional holding shows a decrease in FII participation, but an increase in DII participation. FII holding has decreased from 7.04% in March 2021 to 3.98% in March 2025 while DII holding has increased from 12.66% to 17.59%.
| Metric | 2021 | 2023 | 2025 |
|---|---|---|---|
| Promoter Holding (%) | 72.69 | 68.44 | 68.18 |
| FII Holding (%) | 7.04 | 7.46 | 3.98 |
| DII Holding (%) | 12.66 | 15.09 | 17.59 |
Balanced RiskThe risk assessment for Rossari Biotech indicates a moderate level of concern due to the increasing cash conversion cycle and higher debt levels which raise concerns about working capital management and financial leverage.
Cash Conversion CycleWeakDebt LevelsAverageCash Conversion Cycle
The Cash Conversion Cycle (CCC) has increased from 6 days in March 2019 to 101 days in March 2025. This increase indicates that the company is taking longer to convert its investments in inventory and receivables into cash. This can lead to liquidity issues and increased working capital requirements.
| Metric | 2019 | 2021 | 2023 | 2025 |
|---|---|---|---|---|
| CCC (Days) | 6 | 46 | 80 | 101 |
Debt Levels
Rossari Biotech's borrowings have increased over the years. Total borrowings have risen from ₹8 Cr in March 2019 to ₹218 Cr in March 2025. This increase in debt levels can increase financial risk and interest expenses. The Debt/Equity ratio has also increased.
| Metric | 2019 | 2021 | 2023 | 2025 |
|---|---|---|---|---|
| Total Borrowings (₹ Cr) | 8 | 0 | 74 | 218 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10543.04Bullish
- SMA 20528.08Bullish
- SMA 50514.65Bullish
- EMA 10544.29Bullish
- EMA 20533.76Bullish
- EMA 50522.66Bullish
- DEMA 10557.13Bullish
- DEMA 20548.21Bullish
- DEMA 50529.99Bullish
- TEMA 10560.72Bearish
- TEMA 20556.26Bullish
- TEMA 50539.18Bullish
- MACD11.71Bullish
- ADX42.92Strong Trend
- IndicatorValueSignal
- RSI80.50Overbought
- CCI115.05Overbought
- ROC 98.25Bullish
- ROC 149.41Bullish
- ROC 259.66Bullish
- Stoch K74.24Neutral
- Stoch D71.90Neutral
- IndicatorValueSignal
- BB Upper563.51Neutral
- BB Middle528.08Neutral
- BB Lower492.64Neutral
- ATR11.17Low Volatility
- IndicatorValueSignal
- MFI83.03Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10532.06Bullish
- SMA 20522.74Bullish
- SMA 50516.98Bullish
- EMA 10537.91Bullish
- EMA 20527.54Bullish
- EMA 50520.56Bullish
- DEMA 10552.36Bullish
- DEMA 20539.54Bullish
- DEMA 50524.38Bullish
- TEMA 10558.79Bearish
- TEMA 20549.84Bullish
- TEMA 50526.98Bullish
- MACD10.39Bullish
- ADX31.32Strong Trend
- IndicatorValueSignal
- RSI76.43Overbought
- CCI164.78Overbought
- ROC 99.19Bullish
- ROC 149.46Bullish
- ROC 2513.85Bullish
- Stoch K72.06Neutral
- Stoch D70.37Neutral
- IndicatorValueSignal
- BB Upper555.34Overbought
- BB Middle522.74Neutral
- BB Lower490.14Neutral
- ATR12.96Low Volatility
- IndicatorValueSignal
- MFI88.21Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10522.50Bullish
- SMA 20514.02Bullish
- SMA 50518.83Bullish
- EMA 10527.23Bullish
- EMA 20521.04Bullish
- EMA 50515.14Bullish
- DEMA 10538.82Bullish
- DEMA 20525.99Bullish
- DEMA 50528.26Bullish
- TEMA 10548.10Bullish
- TEMA 20531.97Bullish
- TEMA 50N/AN/A
- MACD5.19Bullish
- ADX21.62Weak Trend
- IndicatorValueSignal
- RSI70.34Overbought
- CCI310.76Overbought
- ROC 98.31Bullish
- ROC 1410.35Bullish
- ROC 254.06Bullish
- Stoch K78.18Neutral
- Stoch D78.73Neutral
- IndicatorValueSignal
- BB Upper545.29Overbought
- BB Middle514.02Neutral
- BB Lower482.75Neutral
- ATR16.36High Volatility
- IndicatorValueSignal
- MFI89.97Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10516.25Bullish
- SMA 20523.63Bullish
- SMA 50506.63Bullish
- SMA 100495.55Bullish
- SMA 200554.30Bullish
- EMA 10524.58Bullish
- EMA 20520.12Bullish
- EMA 50509.42Bullish
- EMA 100514.64Bullish
- EMA 200550.13Bullish
- DEMA 10531.18Bullish
- DEMA 20527.84Bullish
- DEMA 50517.81Bullish
- DEMA 100486.92Bullish
- DEMA 200477.19Bullish
- TEMA 10537.92Bullish
- TEMA 20526.18Bullish
- TEMA 50536.10Bullish
- TEMA 100505.97Bullish
- TEMA 200469.41Bullish
- MACD5.83Bullish
- ADX17.24Weak Trend
- IndicatorValueSignal
- RSI64.56Neutral
- CCI167.73Overbought
- ROC 147.42Bullish
- ROC 257.62Bullish
- Stoch K69.05Neutral
- Stoch D56.44Neutral
- IndicatorValueSignal
- BB Upper555.66Overbought
- BB Middle523.63Neutral
- BB Lower491.59Neutral
- ATR22.67High Volatility
- IndicatorValueSignal
- MFI74.02Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 20490.71Bullish
- SMA 50574.80Bearish
- EMA 20511.37Bearish
- EMA 50562.91Bearish
- DEMA 20486.32Bullish
- DEMA 50481.10Bullish
- TEMA 20504.11Bearish
- TEMA 50464.75Bullish
- MACD-14.85Bullish
- ADX20.25Weak Trend
- IndicatorValueSignal
- RSI44.99Neutral
- CCI-69.30Neutral
- ROC 147.91Bullish
- ROC 25-11.55Bearish
- Stoch K76.54Neutral
- Stoch D77.73Neutral
- IndicatorValueSignal
- BB Upper573.88Neutral
- BB Middle490.71Neutral
- BB Lower407.54Neutral
- ATR46.06Low Volatility
- IndicatorValueSignal
- MFI57.40Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 6503.20Bullish
- SMA 12574.37Bearish
- SMA 24666.98Bearish
- EMA 6510.23Bullish
- EMA 12558.02Bearish
- EMA 24628.59Bearish
- DEMA 6470.07Bullish
- DEMA 12478.14Bullish
- DEMA 24514.12Bullish
- TEMA 6476.42Bullish
- TEMA 12460.36Bullish
- TEMA 24486.11Bullish
- MACD-137.37Bearish
- ADX17.41Weak Trend
- IndicatorValueSignal
- RSI45.00Neutral
- CCI-140.61Oversold
- ROC 25-30.75Bearish
- ROC 50-43.08Bearish
- Stoch K15.77Oversold
- Stoch D29.84Neutral
- IndicatorValueSignal
- BB Upper843.84Neutral
- BB Middle627.14Neutral
- BB Lower410.43Neutral
- ATR104.06Low Volatility
- IndicatorValueSignal
- MFI76.16Neutral